XIMINO Drug Patent Profile
✉ Email this page to a colleague
When do Ximino patents expire, and what generic alternatives are available?
Ximino is a drug marketed by Journey and is included in one NDA. There are three patents protecting this drug.
This drug has twelve patent family members in nine countries.
The generic ingredient in XIMINO is minocycline hydrochloride. There are fifteen drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the minocycline hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ximino
A generic version of XIMINO was approved as minocycline hydrochloride by WATSON LABS on December 30th, 1991.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for XIMINO?
- What are the global sales for XIMINO?
- What is Average Wholesale Price for XIMINO?
Summary for XIMINO
| International Patents: | 12 |
| US Patents: | 3 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Patent Applications: | 2,725 |
| Drug Prices: | Drug price information for XIMINO |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for XIMINO |
| What excipients (inactive ingredients) are in XIMINO? | XIMINO excipients list |
| DailyMed Link: | XIMINO at DailyMed |
US Patents and Regulatory Information for XIMINO
XIMINO is protected by three US patents.
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Journey | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-001 | Jul 11, 2012 | DISCN | No | No | 7,541,347 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Journey | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-003 | Jul 11, 2012 | DISCN | No | No | 7,544,373 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Journey | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-002 | Jul 11, 2012 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Journey | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-004 | Jul 11, 2012 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Journey | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-001 | Jul 11, 2012 | DISCN | No | No | 7,919,483 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Journey | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-001 | Jul 11, 2012 | DISCN | No | No | 7,544,373 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for XIMINO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Journey | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-003 | Jul 11, 2012 | 7,790,705 | ⤷ Start Trial |
| Journey | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-003 | Jul 11, 2012 | 8,252,776 | ⤷ Start Trial |
| Journey | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-001 | Jul 11, 2012 | 8,268,804 | ⤷ Start Trial |
| Journey | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-001 | Jul 11, 2012 | 5,908,838 | ⤷ Start Trial |
| Journey | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-005 | Jul 11, 2012 | 8,252,776 | ⤷ Start Trial |
| Journey | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-001 | Jul 11, 2012 | 8,252,776 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for XIMINO
See the table below for patents covering XIMINO around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Australia | 2006262428 | Method for the treatment of acne | ⤷ Start Trial |
| Canada | 2613273 | METHODE DE TRAITEMENT DE L'ACNE (METHOD FOR THE TREATMENT OF ACNE) | ⤷ Start Trial |
| China | 101208097 | Method for the treatment of acne | ⤷ Start Trial |
| European Patent Office | 1898925 | MÉTHODE DE TRAITEMENT DE L'ACNÉ (METHOD FOR THE TREATMENT OF ACNE) | ⤷ Start Trial |
| Japan | 2008543936 | ⤷ Start Trial | |
| Japan | 2013213047 | にきびの治療方法発明の分野 (METHOD FOR TREATMENT OF ACNE) | ⤷ Start Trial |
| >Country | >Patent Number | >Title | >Estimated Expiration |
More… ↓


